Data / Form D filings / Sight Sciences, Inc.
Sight Sciences, Inc.: Form D filings
Sight Sciences, Inc., a biotechnology company in Menlo Park, CA, filed 9 Form D notices with the SEC between 2011 and 2020. The latest, on December 10, 2020, reports $23.2 million sold of a $23.2 million offering to 4 investors.
Find out what Sight Sciences, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 4040 CAMPBELL AVENUE, SUITE 100, Menlo Park, CA, 94025
- Phone
- (877) 266-1144
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1531177
The full lists. Form D filings in California: 5,891 rows, $138.91, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Dec 10, 2020 | New notice | $23,249,972 | $23,249,972 | $0 | 4 | Nov 23, 2020 | sec.gov |
| Apr 14, 2020 | Amendment | $30,500,000 | $30,150,002 | $349,998 | 4 | Mar 17, 2020 | sec.gov |
| Apr 14, 2020 | New notice | $30,500,000 | $30,150,002 | $349,998 | 0 | Mar 17, 2020 | sec.gov |
| Sep 10, 2019 | Amendment | $31,502,481 | $30,749,980 | $752,501 | 2 | Aug 9, 2019 | sec.gov |
| Aug 26, 2019 | New notice | $31,502,481 | $30,749,980 | $752,501 | 2 | Aug 9, 2019 | sec.gov |
| Jun 4, 2018 | Amendment | $22,226,216 | $19,726,217 | $2,499,999 | 25 | Jul 7, 2017 | sec.gov |
| Jul 20, 2017 | New notice | $10,000,000 | $10,000,000 | $0 | 15 | Jul 7, 2017 | sec.gov |
| Oct 30, 2015 | New notice | $7,000,000 | $6,939,969 | $60,031 | 17 | Oct 16, 2015 | sec.gov |
| Sep 28, 2011 | New notice | $5,249,995 | $524,995 | $4,725,000 | 6 | Sep 12, 2011 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Paul Badawi | Executive Officer, Director | |
| Jesse Selnick | Executive Officer | |
| David Badawi | Director | |
| Staffan Encrantz | Director | |
| Mack Hicks | Director | |
| Valeska Schroeder | Director | |
| Erica Rogers | Director | |
| Andrew Offer | Director | |
| Don Zurbay | Director |
Other biotechnology companies in California that filed recently
- CARI Health, Inc. $280,000 · Nov 6, 2026
- Ausel, Inc. $120,000 · Nov 4, 2026
- Trellis Bioscience, Inc. $9.1 million · Oct 29, 2026
- BigHat Biosciences, Inc. $75.1 million · Oct 26, 2026
- Theravie Pharma, Inc. $750,000 · Oct 19, 2026
- Adela, Inc. $12 million · Oct 19, 2026
Every Form D from the week of Dec 7, 2020 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Sight Sciences, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.